Literature DB >> 12730375

Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Susan Moir1, Kisani M Ogwaro, Angela Malaspina, Joshua Vasquez, Eileen T Donoghue, Claire W Hallahan, Shuying Liu, Linda A Ehler, Marie A Planta, Shyamasundaran Kottilil, Tae-Wook Chun, Anthony S Fauci.   

Abstract

HIV infection induces a wide array of B cell dysfunctions. We have characterized the effect of plasma viremia on the responsiveness of B cells to CD4(+) T cell help in HIV-infected patients. In HIV-negative donors, B cell proliferation correlated with CD154 expression on activated CD4(+) T cells and with the availability of IL-2, whereas in HIV-infected viremic patients, reduced B cell proliferation was observed despite normal CD154 expression on activated CD4(+) T cells. Reduced triggering of B cells by activated CD4(+) T cells was clearly observed in HIV-infected viremic patients compared with aviremic patients with comparable CD4(+) T cell counts, and a dramatic improvement in B cell function was observed in patients whose plasma viremia was controlled by effective antiretroviral therapy. The degree of B cell dysfunction in viremic patients correlated strongly with the inability of B cells to express CD25 in response to activated CD4(+) T cells, resulting in an inability to mount a normal proliferative response to IL-2. Similar defects in responsiveness to IL-2 were observed in the B cells of HIV-infected viremic patients in the context of B cell receptor stimulation. These data provide new insight into the mechanisms associated with ineffective humoral responses in HIV disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730375      PMCID: PMC156325          DOI: 10.1073/pnas.0730819100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.

Authors:  M C Steinhoff; B S Auerbach; K E Nelson; D Vlahov; R L Becker; N M Graham; D H Schwartz; A H Lucas; R E Chaisson
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

Review 2.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25).

Authors:  H Zola; L Y Koh; B X Mantzioris; D Rhodes
Journal:  Clin Immunol Immunopathol       Date:  1991-04

4.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection.

Authors:  R Pahwa; R A Good; S Pahwa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth.

Authors:  D Blanchard; C Gaillard; P Hermann; J Banchereau
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

7.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

8.  Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.

Authors:  A Shirai; M Cosentino; S F Leitman-Klinman; D M Klinman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

9.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Authors:  F Miedema; A J Petit; F G Terpstra; J K Schattenkerk; F de Wolf; B J Al; M Roos; J M Lange; S A Danner; J Goudsmit
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

10.  IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.

Authors:  John F McDyer; Zhuqing Li; Susan John; Xiang Yu; Chang-You Wu; Jack A Ragheb
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  42 in total

1.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.

Authors:  Madhumita Mahalanabis; Pushpa Jayaraman; Toshiyuki Miura; Florencia Pereyra; E Michael Chester; Barbra Richardson; Bruce Walker; Nancy L Haigwood
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).

Authors:  Heather M Kling; Timothy W Shipley; Karen A Norris
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

4.  Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.

Authors:  Steven G Deeks; Becky Schweighardt; Terri Wrin; Justin Galovich; Rebecca Hoh; Elizabeth Sinclair; Peter Hunt; Joseph M McCune; Jeffrey N Martin; Christos J Petropoulos; Frederick M Hecht
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.

Authors:  Arpita Choudhury; Philip L Cohen; Robert A Eisenberg
Journal:  Clin Immunol       Date:  2010-04-08       Impact factor: 3.969

6.  HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.

Authors:  Kimdar Sherefa Kemal; Brian Foley; Harold Burger; Kathryn Anastos; Howard Minkoff; Christina Kitchen; Sean M Philpott; Wei Gao; Esther Robison; Susan Holman; Carolyn Dehner; Suzanne Beck; William A Meyer; Alan Landay; Andrea Kovacs; James Bremer; Barbara Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

7.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.

Authors:  Adriana Weinberg; Sharon Huang; Terence Fenton; Julie Patterson-Bartlett; Philimon Gona; Jennifer S Read; Wayne M Dankner; Sharon Nachman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

Review 9.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Authors:  Weifeng Xu; Paul A Santini; John S Sullivan; Bing He; Meimei Shan; Susan C Ball; Wayne B Dyer; Thomas J Ketas; Amy Chadburn; Leona Cohen-Gould; Daniel M Knowles; April Chiu; Rogier W Sanders; Kang Chen; Andrea Cerutti
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.